Synthesis and antioxidant properties of novel N-H and N-substituted propanamide derivatives

Archiv der Pharmazie

Volumn 340, Issue 3, 2007, Pages 140-146

  Ölgen, Süreyya ^a   Kiliç, Zuhal ^a   Ada, Ahmet O ^a   Çoban, Tülay ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Indole 3 propionic acid; Inhibition; Lipid peroxidation; Superoxide dismutase; Synthesis

Indexed keywords

ALPHA TOCOPHEROL; INDOLE 3 PROPANAMIDE; NITROGEN; PROPIONAMIDE DERIVATIVE; SUPEROXIDE; UNCLASSIFIED DRUG; AMIDE; ANTIOXIDANT; ENZYME INHIBITOR; INDOLE DERIVATIVE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; ANIMAL; CHEMICAL STRUCTURE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; LIVER MICROSOME; METABOLISM; SYNTHESIS; WISTAR RAT;

AMIDES; ANIMALS; ANTIOXIDANTS; ENZYME INHIBITORS; INDOLES; LIPID PEROXIDATION; MALE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE;

EID: 34250313267     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200600176     Document Type: Article

References (25)

1. L. Packer, H. J. Tritschler, K. Wessel, Free Rad. Biol. Med. 1997, 22, 359-378.
2. H. J. Thompson, J. Nutr. 2004, 134, 3186S-3187S.
3. M. Valko, M. Izakovich, M. Mazur, C. J. Rhodes, J. Telser, Mol. Cell Biochem. 2004, 266, 37-56.
4. J. J. Piotrowski, G. C. Hunter, C. D. Eskelson, M. A. Dubick, V. M. Bernhard, Life Sci. 1990, 46, 715-721.
5. C. Kuehm-Caubere, P. Caubere, B. Jamart-Gregoire, A. Negre-Salvayre, et al., J. Med. Chem. 1997, 40, 1201-1210.
6. S. Ohkawa, S. Terao, Z.-I. Terashita, Y. Shibouta, K. Nishikawa, J. Med. Chem. 1991, 34, 267-276.
7. B. N. Ames, M. K. Shigenaga, T. M. Hagen, Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 7915-7922.
8. F. Iemma, S. Trombino, F. Puoci, G. Cirillo, et al., Macromol. Biosci. 2005, 5, 1049-1056.
9. S. Olgen, E. Guner, M. A. Fabregat, M. I. Crespo, D. Nebioglu, Pharmazie 2002, 57, 238-242.
10. H. Y. Aboul-Enein, I. Kruk, K. Lichszteld, T. Michalska, et al., Luminescence 2004, 19, 1-7.
11. S. Olgen, T. Coban, Biol. Pharm. Bull. 2003, 26, 736-738.
12. S. Olgen, T. Coban, Arch. Pharm. Med. Chem. 2002, 7, 331-338.
13. H. Y. Aboul-Enein, I. Kruk, K. Lichszteld, T. Michalska, et al., Biopolymers 2005, 78, 171-178.
14. S. Olgen, E. Akaho, D. Nebioglu, Farmaco 2005, 60, 497-506.
15. A. Organesian, J. D. Hendricks, D. E. Williams, Cancer Lett. 1997, 118, 87-94.
16. I. Andreadou, A. Tsantili-Kakoulidou, E. Spyropoulou, T. Siatra, Chem. Pharm. Bull. 2003, 51, 1128-1131.
17. D.-S. Kim, S.-E. Jeon, K.-C. Park, Cell. Signal. 2004, 16, 81-88.
18. S. H. Benanadhi, J.-B. Zheng, X.-C. Dong, S.-G. Yuan, Acta Pharmacol. Sin. 2004, 25, 666-671.
19. G. Spadoni, G. Diamantini, A. Bendini, G. Tarzia, et al., J. Pineal Res. 2006, 40, 259-269.
20. Z. Ates-Alagoz, C. Kus, T. Coban, J. Enzym. Inh. Med. Chem. 2005, 20, 325-331.
21. Z. Ates-Alagoz, T. Coban, E. Buyukbingol, Arch. Pharm. Life Sci. 2006, 339, 193-200.
22. S. Battaglia, E. Boldrini, F. Da Settimo, G. Dondio, et al., Eur. J. Med. Chem. 1999, 34, 93-105.
23. M. Mihara, M. S. Uchiyama, K. Fukuzawa, Biochem. Med. 1980, 23, 303-311.
24. J. M. McCord, J. M. Fridovich, Methods Enzymol. 1978, 53, 382-393.
25. J. Antosiewich, E. Damiani, W. Jassem, M. Wozniak, et al., Free Rad. Biol. Med. 1997, 22, 249-255.